Myasthenia gravis, a rare disease in children, occurs in a variety of forms. The aetiology and clinical presentations are reviewed. Eight patients who were studied with electromyography are presented. The results show that, in general, patients with the usual pattern of disease are resistant to suxamethonium (ED95 3–4 times normal) and are sensitive to nondepolarizing relaxants. When the latter are used it is advisable to administer small increments with neuromuscular monitoring. One patient with the disease localised to the eyelid had normal EMG responses when monitored on the hand with ulnar nerve stimulation.
RodriguizM., GomezM.R., HowardF.M., TaylorW.F.Myasthenia gravis in children: long term follow up. Annals of Neurology1983; 13: 504–510.
3.
JollyF.Ueber Myasthenia gravis pseudoparalytica. Ber Klin Wschr1895; 32: 1 (In: Wylie WD, Churchill Davidson HC — A Practice of Anaesthesia).
4.
Churchill DavidsonH.C., RichardsonA.T.Myasthenia gravis: Therapeutic use of d-tubocurarine. Lancet1957; 1: 1221.
5.
LeventhalS.R., OrkinF.K., HirshR.A.Predicting postoperative ventilatory need in myasthenia. Anesthesiology1979; 61: S151.
6.
LamH.S., CassN.M., NgK.C.Electromyographic monitoring of neuromuscular block. Brit J Anaesth1981; 53: 1351–1357.
7.
MeretojaO.A., BrownT.C.K., ClareD.Dose responses to alcuronium and d-tubocurarine in infants children and adolescents. Anaesth Intens Care1990; 18: 449–451.
8.
MeretojaO.A., WirtavuoriK.Influence of age on the dose response relationship of atracurium in paediatric patients. Acta Anaesth Scand1988; 32: 614–618.
BrownT.C.K., MeretojaO.A., ClareD., BellB.Does suxamethonium influence the subsequent dose requirements of alcuronium and its reversibility?Anaesth Intens Care1990; 18: 479–482.
11.
BellC.F., FlorenceA.M., HunterJ.M.Atracurium in the myasthenic patient. Anaesthesia1984; 39: 961–968.
12.
WardS., WrightD.J.Neuromuscular blockade in myasthenia gravis with atracurium besylate. Anaesthesia1984; 39: 51–53.